Search clinical trials for: Intranasal esketamine (56 mg)

Total 136 results

Universidade Federal de Goias
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Completed

Midazolam and Ketamine Effect Administered Through the Nose for Sedation of Children for Dental Treatment (NASO)

Dental Caries | Child Behavior

Brazil
Evelyne D.Trottier

Completed

Pain Free Laceration Repairs Using Intra-nasal Ketamine

Laceration

Canada
University of Calgary
University of British Columbia

Completed

Pre-hospital Care With Intra-Nasal Ketamine for Transport (PRECINKT): A Pilot Study (PRECINKT)

Pain | Traumatic Limb Injury

Canada
Javelin Pharmaceuticals

Completed

Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain

Pain, Postoperative
Javelin Pharmaceuticals

Completed

Multiple Dose Pharmacokinetics of Intranasal Ketamine

Healthy
Antonios Likourezos

Recruiting

Nebulized Sub-dissociative Dose Ketamine at Three Different Dosing Regimens for Treating Acute Pain in the Pediatric ED

Pain

United States
Ayesha De Costa
Boston Children's Hospital; Muhimbili University of Health and Allied Sciences and other collaborators

Completed

Zinc Dosing Trial - Does Dose Reduction Reduce Side Effects But Retain Efficacy in Diarrhoea Management (ZTDT)

Diarrhea

Tanzania, India
Abigail Nixon

Recruiting

Intranasal Ketamine For Pain Control In Patients With Sickle Cell Disease And Vaso-occlusive Episode (VOE) In The PED

Analgesia | Sickle Cell Disease | Ketamine | Vaso-occlusive Crisis | Vaso-Occlusive Pain Episode in Sickle Cell Disease | Intranasal Ketamine

United States
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery

Pain, Postoperative

United States
Wuhan Union Hospital, China

Recruiting

Esketamine Induction Intubation in ICU Patients.

Critically Ill Patients

China
Hospira, now a wholly owned subsidiary of Pfizer

Terminated

Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients

Pain | Cancer

United States
Javelin Pharmaceuticals

Unknown

Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine

Pharmacokinetics

United States
Pontificia Universidade Catolica de Sao Paulo

Completed

Low Doses of Ketamine and Postoperative Quality of Recovery

Postoperative Pain | Postoperative Nausea and Vomiting

Brazil
Association Asthma, Bulgaria
Nasaleze

Unknown

4"S" - Seasonal Symptoms Suppression Study (4"S")

Seasonal Allergic Rhinitis

Bulgaria
Washington University School of Medicine
Harvard Medical School (HMS and HSDM); University of Manitoba; University Health... and other collaborators

Completed

The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial (PODCAST)

Delirium

United States
Centre for Addiction and Mental Health

Completed

Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders) (SURE-ECT)

Depression

Canada
The University of Texas Health Science Center,...

Completed

Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse

Depression | Suicidal Ideation | Alcohol Abuse

United States
University of Cincinnati

Unknown

Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)

Major Depressive Disorder
Adapt Produtos Oftalmológicos Ltda.

Withdrawn

Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH

Ocular Hypertension | Open Angle Glaucoma

Brazil
Danish University of Pharmaceutical Sciences
Rigshospitalet, Denmark

Completed

Nasal Administration of Sufentanil+Ketamine for Procedure-related Pain in Children

Pain

Denmark
Zosano Pharma Corporation

Completed

Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers

Migraine

United States
University of Sao Paulo General Hospital

Unknown

Intranasal Versus Intravenous Drug in Painful Procedure for Outpatient Oncologic Participants (NAIVe)

Analgesia | Pediatric Cancer | Procedural Pain

Brazil
Udayana University

Completed

Comparison of CRP Levels, Neutrophil Count, and Clinical Outcomes of Low Dose Ketamine Between at Anesthesia Induction and at the End of Surgery in Patients Undergo Elective Laparotomy (PRO-Ketamine)

Inflammation | General Anesthesia | Laparotomy

Indonesia
Samsung Medical Center

Recruiting

Phase II Study of Carfilzomib, Pomalidomide, and Dexamethasone for Myeloma Patients Who Had Relapsed or Progressed After Carfilzomib, Lenalidomide, and Dexamethasone (KMM2002)

Multiple Myeloma

Korea, Republic of
University of Arkansas

Not yet recruiting

Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room

Pain | Anxiety | Acute Stress Disorder

United States
Seelos Therapeutics, Inc.

Completed

A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide

Depressive Disorder, Major | Suicidal

United States
New York State Psychiatric Institute

Completed

Glutamatergic Modulation of Cocaine-related Deficits

Cocaine Dependence

United States
Leiden University Medical Center
U.S. Food and Drug Administration (FDA)

Recruiting

Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists (ROAR)

Chronic Opioid Use | Opioid Induced Respiratory Depression

Netherlands
Thomas Steffen
Gottfried und Julia Bangerter-Rhyner Foundation, Switzerland

Terminated

Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy? (CaCo)

Colorectal Neoplasm | Diverticulitis | Postoperative Ileus | Laparoscopic Colectomy Without Stoma Formation

Switzerland
Javelin Pharmaceuticals

Completed

Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)

Healthy

United States
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Pharmacokinetics and Pharmacodynamics of a New Formulation of Nasal Naloxone for Prehospital Use (OPI-14-001)

Drug Overdose

Norway
Janssen Research & Development, LLC

Completed

Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide

Depressive Disorder, Major

United States, France, Italy, Spain, Hungary, Belgium, Brazil, Bulgaria, Poland
North Memorial Health Care

Completed

Low Dose Ketamine for Blunt Thoracic Trauma

Blunt Injury of Thorax | Multiple Rib Fractures, Involving Three Ribs

United States
Northwestern University

Active, not recruiting

Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries

Pain | Postpartum Depression

United States
Adriana Feder

Withdrawn

To Test the Potential Efficacy of Repeated Intranasal Administration of Ketamine as a Treatment for PTSD

PTSD
National Institute of Neurology and Neurosurgery...

Unknown

Evaluation of Schemes of Administration of Intravenous Ketamine in Depression

Treatment Resistant Depression

Mexico
University of Miami
Acerus Pharmaceuticals Corporation

Completed

A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections

Hypogonadism, Male

United States
Ajou University School of Medicine
Unimedics (http://unimedics.co.kr)

Terminated

Comparison of Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients

Trauma | Shock, Traumatic

Korea, Republic of
Assiut University

Completed

Dexmedetomidine Versus Midazolam Added to Ketamine in Pediatric Patients Undergoing Bone Marrow Aspiration and Biopsy

Procedural Sedation and Analgesia During Bone Marrow Aspiration and Biopsy

Egypt
Janssen Research & Development, LLC

Completed

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression (SUSTAIN-2)

Treatment-resistant Depression

United States, Australia, France, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Poland, Bulgaria, Malaysia, South Africa, Turkey, Finland, Korea, Republic of, Brazil, Austria, Sweden, Lithuania
Wake Forest University Health Sciences

Completed

Sedation Methods During Cataract Surgery

Cataract | Phacoemulsification
Odense University Hospital
Erasmus Medical Center; University of Aarhus; University of Southern Denmark; Odense... and other collaborators

Not yet recruiting

Melatonin fOr CHronic bAck Pain (The MOCHA Trial) (MOCHA)

Insomnia | Back Pain Lower Back Chronic
Seoul National University Hospital

Recruiting

Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Procedural Sedation in Children

Sedation

Korea, Republic of
Ain Shams University

Recruiting

Melatonin as an Analgesic in Preterm Neonate

Preterm Neonate Analgesia

Egypt
Wake Forest University Health Sciences

Recruiting

SNIFF - Combo INI+EMPA Trial

Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions

Healthy

Canada
Dow University of Health Sciences

Completed

Efficacy of Zinc on Concurrent Chemo-radiotherapy Induced Taste Alterations

Taste, Altered

Pakistan
United States Naval Medical Center, San Diego

Withdrawn

A Study to Decrease Suicidal Thinking Using Ketamine

Depression | Suicide

United States
Seoul National University Hospital

Not yet recruiting

Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Rescue After Failed Pediatric Procedural Sedation

Sedation

Korea, Republic of
Northwell Health

Withdrawn

Ketamine-Assisted PsychoTherapy ViAbility in Treating Cancer-related Emotional Distress (KAPTIVATED)

Anxiety Disorders | Depressive Symptoms | Cancer-related Problem/Condition

Search clinical trials for: Intranasal esketamine (56 mg)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations